Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABSINYSE:MPLNNASDAQ:RPAYNASDAQ:RSSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSIAbsci$2.76+2.4%$2.81$2.01▼$6.33$353.34M2.012.89 million shs2.71 million shsMPLNMultiPlan$45.43+6.9%$32.45$4.80▼$29.84$734.65M0.13116,920 shs64,120 shsRPAYRepay$5.02+2.5%$4.52$3.59▼$10.16$499.19M1.591.09 million shs631,079 shsRSSSResearch Solutions$3.05+3.4%$2.84$2.32▼$4.24$98.68M0.6784,562 shs25,941 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSIAbsci0.00%+5.15%-3.33%+20.83%-13.36%MPLNMultiPlan+6.89%+6.27%+20.86%+127.04%+4,542,999,900.00%RPAYRepay0.00%+5.55%+1.29%-1.68%-46.67%RSSSResearch Solutions0.00%+6.27%+7.77%+21.51%+22.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSIAbsci2.0441 of 5 stars3.51.00.00.01.81.70.6MPLNMultiPlan0.1866 of 5 stars1.00.00.00.00.01.70.6RPAYRepay4.0593 of 5 stars4.32.00.00.02.64.21.3RSSSResearch Solutions1.0681 of 5 stars0.03.00.00.01.10.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSIAbsci 3.00Buy$8.40204.90% UpsideMPLNMultiPlan 2.00Hold$26.25-42.22% DownsideRPAYRepay 2.56Moderate Buy$7.9057.25% UpsideRSSSResearch Solutions 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RSSS, ABSI, RPAY, and MPLN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025ABSIAbsciMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$7.005/19/2025RPAYRepayCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.00 ➝ $4.505/14/2025RPAYRepayMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$4.505/14/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.005/13/2025RPAYRepayBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$7.00 ➝ $5.005/13/2025RPAYRepayKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $4.505/13/2025RPAYRepayUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$7.50 ➝ $4.504/16/2025ABSIAbsciKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$5.00 ➝ $9.004/14/2025RPAYRepayBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$9.00 ➝ $6.004/9/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSIAbsci$4.53M77.58N/AN/A$1.56 per share1.77MPLNMultiPlan$930.62M0.79$27.70 per share1.64$105.45 per share0.43RPAYRepay$313.04M1.60$1.99 per share2.53$8.76 per share0.57RSSSResearch Solutions$44.62M2.22$0.01 per share343.14$0.36 per share8.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSIAbsci-$103.11M-$0.92N/AN/AN/A-2,232.13%-53.69%-45.89%8/13/2025 (Estimated)MPLNMultiPlan-$91.70M-$101.54N/AN/AN/A-163.30%-12.14%-1.84%N/ARPAYRepay-$10.16M-$0.15N/A6.52N/A-4.16%8.49%4.31%8/6/2025 (Estimated)RSSSResearch Solutions-$3.79M-$0.14N/A50.833.38-8.03%-5.80%-1.59%9/18/2025 (Estimated)Latest RSSS, ABSI, RPAY, and MPLN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025ABSIAbsci-$0.23-$0.21+$0.02-$0.21$1.07 million$1.18 million5/12/2025Q1 2025RPAYRepay$0.23$0.22-$0.01-$0.09$76.06 million$77.33 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSIAbsciN/AN/AN/AN/AN/AMPLNMultiPlanN/AN/AN/AN/AN/ARPAYRepayN/AN/AN/AN/AN/ARSSSResearch SolutionsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABSIAbsciN/A5.725.72MPLNMultiPlan21.731.051.05RPAYRepay0.653.713.71RSSSResearch SolutionsN/A0.760.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSIAbsci52.05%MPLNMultiPlan87.15%RPAYRepay82.73%RSSSResearch Solutions33.60%Insider OwnershipCompanyInsider OwnershipABSIAbsci10.49%MPLNMultiPlan8.00%RPAYRepay12.00%RSSSResearch Solutions12.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSIAbsci210127.56 million114.18 millionOptionableMPLNMultiPlan17016.17 million14.88 millionOptionableRPAYRepay58099.44 million87.51 millionOptionableRSSSResearch Solutions13032.46 million28.27 millionNot OptionableRSSS, ABSI, RPAY, and MPLN HeadlinesRecent News About These CompaniesResearch in Life and Environmental SciencesJuly 4 at 7:06 AM | birmingham.ac.ukBPadilla Bay National Estuarine Research Reserve begins free aquarium toursJuly 4 at 2:06 AM | goskagit.comGSurvey from Pew Research looks at TV viewing habits in era of cord-cuttingJuly 4 at 2:06 AM | baltimoresun.comBPurdue Research Foundation's Quest for Amelia Earhart's PlaneJuly 3 at 4:04 PM | wibc.comWAgriLife Research reimagines citrus greening treatment deliveryJuly 3 at 4:04 PM | agrilifetoday.tamu.eduAACT Research: Preliminary Classes 5-8 Net Orders Declined in JuneJuly 3 at 4:04 PM | monitordaily.comMNew Research Highlights Dangers Of Ultra-Processed FoodJuly 3 at 4:04 PM | finanznachrichten.deAATCC Foundation: New Funding Available For Textile ResearchJuly 3 at 4:04 PM | textileworld.comTHow Pennington Biomedical Research Center looks to offset $4.1 million cut in federal fundsJuly 3 at 4:04 PM | theadvocate.comTEight sunscreens that failed their SPF claims tested by same lab, Princeton Consumer ResearchJuly 3 at 4:04 PM | msn.comAmistad Research Center struggles to preserve Black history after major funding cutsJuly 2 at 5:35 PM | msn.comResearch warns even low levels of air pollution can hurt heartsJuly 2 at 5:35 PM | foxbangor.comF70-plus organizations relaunch Business for Federal Research Funding CoalitionJuly 2 at 5:35 PM | businessrecord.comBCall for applications: Faculty Fellows in the Division of Research and Economic DevelopmentJuly 2 at 5:35 PM | boisestate.eduBA New Home — And Future — For Forbes ResearchJuly 2 at 5:35 PM | msn.comUVM Announces Food Systems Research InstituteJuly 2 at 5:35 PM | uvm.eduUMaking A Winning Go-To-Market Strategy By Leveraging Market ResearchJuly 2 at 5:35 PM | forbes.comThe Georgia Cancer Center hold their 3rd Summer Research ExperienceJuly 2 at 5:35 PM | yahoo.comPurdue Research Foundation to help lead expedition to locate lost Amelia Earhart aircraftJuly 2 at 5:35 PM | yahoo.comAuriga, SFRI Partner for AI-Driven Healthcare ResearchJuly 2 at 7:32 AM | money.rediff.comMResearch Solutions, Inc. (NASDAQ:RSSS) Short Interest UpdateJune 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRSSS, ABSI, RPAY, and MPLN Company DescriptionsAbsci NASDAQ:ABSI$2.76 +0.07 (+2.42%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$2.77 +0.02 (+0.69%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.MultiPlan NYSE:MPLN$45.43 +2.93 (+6.89%) As of 07/3/2025MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.Repay NASDAQ:RPAY$5.02 +0.12 (+2.53%) Closing price 07/3/2025 03:12 PM EasternExtended Trading$5.03 +0.00 (+0.02%) As of 07/3/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Repay Holdings Corporation, payments technology company, provides integrated payment processing solutions to industry-oriented markets in the United States. It operates through two segments: Consumer Payments and Business Payments. The company's payment processing solutions enable consumers and businesses to make payments using electronic payment methods. It also offers a range of solutions relating to electronic payment methods, including credit and debit card processing, automated clearing house (ACH) processing, e-cash, and digital wallet services; virtual credit card processing, enhanced ACH processing, instant funding, clearing and settlement, and communication solutions; and proprietary payment channels that include Web-based, virtual terminal, online client portal, mobile application, text-to-pay, interactive voice response, and point of sale services. It serves customers primarily operating in the personal loans, automotive loans, receivables management, and business-to-business verticals through direct sales representatives and software integration partners. The company was founded in 2006 and is headquartered in Atlanta, Georgia.Research Solutions NASDAQ:RSSS$3.05 +0.10 (+3.39%) Closing price 07/3/2025 03:15 PM EasternExtended Trading$3.07 +0.02 (+0.79%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets. The company also offers Article Galaxy, a solution that allows research organizations to load their entitlements, consisting of subscriptions, discount or token packages, and their existing library of articles. In addition, it provides Manage platform, a references solution that allows users to access the article inside the platform including setting up personal folders or team folders and allows researchers to markup and take notes on the articles in a supported browser on a desktop or tablet. Further, the company's platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
